Formulary Watch |

All News - Page 69

Major Metformin recalls underway
Major Metformin recalls underway
Major Metformin recalls underway
June 8, 2020
Five pharma markers are recalling the diabetes medication due to the presence of a carcinogenic ingredient.
Remdesivir for COVID-19 in short supply
Remdesivir for COVID-19 in short supply
Remdesivir for COVID-19 in short supply
June 8, 2020
HHS says supply could run out by the end of this month.
New antibiotic for hospital-acquired pneumonia available
New antibiotic for hospital-acquired pneumonia available
New antibiotic for hospital-acquired pneumonia available
June 5, 2020
The agency welcomes another option for serious bacterial infections.
Drug’s indication expanded to reduce heart attack, stroke risk
Drug’s indication expanded to reduce heart attack, stroke risk
Drug’s indication expanded to reduce heart attack, stroke risk
June 2, 2020
Brilinta is already approved to prevent atherothrombotic events in ASC.
Two metformin products recalled, more on the way
Two metformin products recalled, more on the way
Two metformin products recalled, more on the way
June 2, 2020
Immediately after the FDA said it found elevated levels of the carcinogenic ingredient N-nitrosodimethylamine (NDMA) in certain extended release (ER) metformin products, the first 2 major recalls are underway.
FDA approves med for severe malaria
FDA approves med for severe malaria
FDA approves med for severe malaria
May 28, 2020
IV artesunate is the only drug available in the U.S. to treat the disease.
Pharma maker recalls drug over undeclared anti-hypertensive drug
Pharma maker recalls drug over undeclared anti-hypertensive drug
Pharma maker recalls drug over undeclared anti-hypertensive drug
May 19, 2020
Top 3 COVID-19 stories this week
Top 3 COVID-19 stories this week
Top 3 COVID-19 stories this week
May 19, 2020
FDA authorizes first stand-alone, at-home test, plus other top COVID-19 news stories.
FDA clears new antigen, saliva tests for COVID-19
FDA clears new antigen, saliva tests for COVID-19
FDA clears new antigen, saliva tests for COVID-19
May 11, 2020
Antigen tests, a new category, have a major advantage and disadvantage over COVID-19 tests already approved.
FDA: Fraudulent COVID-19 medical products abound
FDA: Fraudulent COVID-19 medical products abound
FDA: Fraudulent COVID-19 medical products abound
May 11, 2020
Numerous PPEs and testing kits also feature unproven coronavirus claims.
New subcutaneous multiple myeloma treatment available
New subcutaneous multiple myeloma treatment available
New subcutaneous multiple myeloma treatment available
May 5, 2020
Formulation could cause fewer administration-related reactions than IV Darzalex.
COVID-19 vaccines could be ready this year, plus other top news
COVID-19 vaccines could be ready this year, plus other top news
COVID-19 vaccines could be ready this year, plus other top news
May 5, 2020
Popular heartburn medication now in shortage due to COVID-19 test.
FDA restricts hydroxychloroquine use, plus other COVID-19 updates
FDA restricts hydroxychloroquine use, plus other COVID-19 updates
FDA restricts hydroxychloroquine use, plus other COVID-19 updates
April 27, 2020
Agency says the anti-malaria drug can cause heart rhythm problems.
FDA warns CBD companies making medical claims
FDA warns CBD companies making medical claims
FDA warns CBD companies making medical claims
April 27, 2020
Suppliers claim CBD can help alleviate opioid addiction, cure diseases.
New lung cancer treatment launches
New lung cancer treatment launches
New lung cancer treatment launches
April 21, 2020
The drug, plus chemotherapy, shows a significant survival benefit.
FDA clears first home COVID-19 test, plus other top news
FDA clears first home COVID-19 test, plus other top news
FDA clears first home COVID-19 test, plus other top news
April 21, 2020
Hospitals could receive $75 billion in funding to combat coronavirus.
Another RA drug starts testing to treat COVID-19
Another RA drug starts testing to treat COVID-19
Another RA drug starts testing to treat COVID-19
April 14, 2020
Olumiant trial joins other RA drug trials, including hydroxychloroquine.
COVID-19 drug price skyrockets, clinical trial begins
COVID-19 drug price skyrockets, clinical trial begins
COVID-19 drug price skyrockets, clinical trial begins
April 14, 2020
An NIH trial on the controversial anti-malaria medication is underway.
Trump, Fauci disagree on the effectiveness of hydroxychloroquine
Trump, Fauci disagree on the effectiveness of hydroxychloroquine
Trump, Fauci disagree on the effectiveness of hydroxychloroquine
April 7, 2020
More COVID-19 patients receive anti-malaria drug despite controversy.
FDA authorizes treatment, rapid test for COVID-19
FDA authorizes treatment, rapid test for COVID-19
FDA authorizes treatment, rapid test for COVID-19
March 30, 2020
Agency issues Emergency Use Authorization for hydroxychloroquine sulfate, along with a novel COVID-19 test.
FDA expands hepatitis C treatment to children
FDA expands hepatitis C treatment to children
FDA expands hepatitis C treatment to children
March 24, 2020
Clinical trial results were similar to those of the drug in adults.
Drugmaker halts access to COVID drug as FDA approves novel test
Drugmaker halts access to COVID drug as FDA approves novel test
Drugmaker halts access to COVID drug as FDA approves novel test
March 24, 2020
First point-of-care test to detect coronavirus cleared.
FDA expedites coronavirus testing kits
FDA expedites coronavirus testing kits
FDA expedites coronavirus testing kits
March 17, 2020
The agency takes other steps to make COVID-19 tests more available.
FDA warning
FDA requires boxed warning on Singulair
FDA requires boxed warning on Singulair
March 16, 2020
New measures taken due to depression, suicidal thoughts, and other adverse events.
Virus
Top 3 Things to Know About Coronavirus Treatments
Top 3 Things to Know About Coronavirus Treatments
March 10, 2020
Discover the latest news on COVID-19 vaccine and drug development.
Warning
FDA, FTC warn suppliers of fraudulent COVID-19 products
FDA, FTC warn suppliers of fraudulent COVID-19 products
March 10, 2020
Companies cited over false coronavirus claims include The Jim Bakker Show.
myeloma
New multiple myeloma treatment works by targeting cells
New multiple myeloma treatment works by targeting cells
March 3, 2020
Isatuximab-irfc (Sarclisa, Sanofi-Aventis) was approved in combination with pomalidomide and dexamethason to treat adult patients with multiple myeloma who have received at least two prior therapies.
Inhaler
FDA clears generic asthma inhaler, inhaled corticosteroid
FDA clears generic asthma inhaler, inhaled corticosteroid
March 3, 2020
Inhaler is the first generic approval of its kind.
Drug Spending
Express Scripts Report: Top Drug Classes Driving Spending Growth
Express Scripts Report: Top Drug Classes Driving Spending Growth
February 25, 2020
Express Scripts’ annual Drug Trend Report highlights top contributors to prescription drug spending in 2019.
Cholesterol Drug
FDA clears first-in-class high cholesterol drug
FDA clears first-in-class high cholesterol drug
February 24, 2020
Treatment is first non-statin LDL-C lowering treatment approved in years.
<1
...
656667686970717273
...
229>
© 2025 MJH Life Sciences

All rights reserved.